Исследования и наука

DREAMM-7 Study Design and the Rationale

Publication of ROADS Phase 3 Clinical Trial Data in Journal of Clinical Oncology Recommends GammaTile® as a New Standard-of-Care Option for Newly Diagnosed Operable Brain Metastases1

Publication of ROADS Phase 3 Clinical Trial Data in Journal of Clinical Oncology Recommends GammaTile® as a New Standard-of-Care Option for Newly Diagnosed Operable Brain Metastases1 PR Newswire

Researchers suggest tile-based radiation therapy as standard of care to lower risk of recurrence in brain metastases

A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center found that implanting collagen tiles during brain surgery to deliver targeted radiation therapy improved tumor control, lowered the risk of recurrence and improved overall survival compared with the current standard of…

Fractionated radiosurgery reduces recurrence after surgery for brain metastases, may improve survival

Mayo Clinic researchers led a multicenter study that found dividing radiation into several treatments, known as fractionated stereotactic radiosurgery, reduced the risk of cancer returning after surgery for brain metastases and was associated with improved survival compared with delivering radiation in a single…

AstraZeneca инвестирует $2 млрд в Summit для исследований рака — TimesLIVE

AstraZeneca инвестирует $2 млрд в Summit для исследований рака — TimesLIVE UA.NEWS

Splitting Brain Radiosurgery into Three to Five Sessions After Tumor Removal Lowered Recurrence in 242-Patient Trial

Splitting Brain Radiosurgery into Three to Five Sessions After Tumor Removal Lowered Recurrence in 242-Patient Trial Medical Daily

FDA Approves Teva’s DEGEVMA Biosimilar to Xgeva for Cancer Bone Complications

FDA Approves Teva’s DEGEVMA Biosimilar to Xgeva for Cancer Bone Complications The Clinical Trial Vanguard

Verastem Oncology Announces Publication in Gynecologic Oncology of Two-Year Median Follow-Up Data from RAMP 201 Study of AVMAPKI® FAKZYNJA® CO-PACK (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cance

Verastem Oncology Announces Publication in Gynecologic Oncology of Two-Year Median Follow-Up Data from RAMP 201 Study of AVMAPKI® FAKZYNJA® CO-PACK (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cance BioSpace

One in eight cancers are likely caused by an infection worldwide – new study

One in eight cancers are likely caused by an infection worldwide – new study The Conversation

Our Analysis: What 195 Trials Reveal About Artificial Intelligence in Oncology

Our Analysis: What 195 Trials Reveal About Artificial Intelligence in Oncology Onco'Zine

Global burden of cancer attributable to infections in 2024: One in eight cancers worldwide linked to infections

Global burden of cancer attributable to infections in 2024: One in eight cancers worldwide linked to infections International Agency for Research on Cancer (IARC)

Global burden of cancer attributable to infections in 2024: One in eight cancers worldwide linked to infections

Global burden of cancer attributable to infections in 2024: One in eight cancers worldwide linked to infections International Agency for Research on Cancer (IARC)

Regulator-mandated study finds no link between semaglutide use and pancreatic cancer

New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, found no link between semaglutide use and pancreatic cancer in nationwide registry data from Denmark, Sweden and Norway. The regulator-mandated post-authorization study was…

“Best wishes for the win ahead! Would be incredible to have an oncologist leading WHO” - Leading Indian-American Translational Research Physician Dr. Vivek Subbiah celebrates Dr Gevorg Tamamyan

“Best wishes for the win ahead! Would be incredible to have an oncologist leading WHO” - Leading Indian-American Translational Research Physician Dr. Vivek Subbiah celebrates Dr Gevorg Tamamyan Oncodaily

Delighted to See the Launch of the International Alliance for Cancer Early Detection’s New Website - Manchester Cancer Research Centre

Delighted to See the Launch of the International Alliance for Cancer Early Detection’s New Website - Manchester Cancer Research Centre Oncodaily